Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53

Oncogene

Volumn 27, Issue 17, 2008, Pages 2382-2389

  Moulin, S ^a   Llanos, S ^a,b   Kim, S H ^a,c   Peters, G ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

ARF; Chicken embryo fibroblasts; MDM2; Nucleolus; Nucleophosmin; p53

Indexed keywords

ARF PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; NUCLEOPHOSMIN; PROTEIN MDM2; PROTEIN P53; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; EMBRYO; HUMAN; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN STABILITY; TUMOR SUPPRESSOR GENE;

MAMMALIA;

EID: 42049122218     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210887     Document Type: Article

References (31)

1. Bertwistle D, Sugimoto M, Sherr CJ. (2004). Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 24:985-996.
2. Brady SN, Yu Y, Maggi Jr B, Weber JD. (2004). ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol Cell Biol 24:9327-9338.
3. Clark PA, Llanos S, Peters G. (2002). Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2. Oncogene 21: 4498-4507.
4. Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC et al. (2005). Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol Cell Biol 25:8874-8886.
5. Colombo E, Marine JC, Danovi D, Falini B, Pelicci PG. (2002). Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 4:529-533 .
6. Colombo E, Martinelli P, Zamponi R, Shing DC, Bonetti P, Luzi L et al. (2006). Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res 66: 3044-3050.
7. den Besten W, Kuo ML, Williams RT, Sherr CJ. (2005). Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein. Cell Cycle 4:1593-15 98.
8. Enomoto T, Lindstrom MS, Jin A, Ke H, Zhang Y. (2006). Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability. J Biol Chem 281:18463-18472 .
9. Freedman DA, Levine AJ. (1998). Nuclear export is required for degradation of endogenous p53 by MDM2 and human papilloma-virus E6. Mol Cell Biol 18:7288-7293.
10. Gil J, Peters G. (2006). Regulation of the INK4b-ARF-INK4a tumour suppressor locus:all for one or one for all. Nat Rev Mol Cell Biol 7: 667-677.
11. Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K et al. (2005). Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437:147-153.
12. Grisendi S, Mecucci C, Falini B, Pandolfi PP. (2006). Nucleophosmin and cancer. Nat Rev Cancer 6:493-505 .
13. Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R et al. (2003). Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 12:11 51-1164.
14. Kim SH, Mitchell M, Fujii H, Llanos S, Peters G. (2003). Absence of p16INK4a and truncation of ARF tumor suppressors in chickens. Proc Natl Acad Sci USA 100:211-216.
15. Kim SH, Rowe J, Fujii H, Jones R, Schmierer B, Kong BW et al. (2006). Upregulation of chicken p15INK4b at senescence and in the developing brain. J Cell Sci 119:2435-24 43.
16. Korgaonkar C, Hagen J, Tompkins V, Frazier AA, Allamargot C, Quelle FW et al. (2005). Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 25:1258-1271.
17. Kuo ML, den Besten W, Bertwistle D, Roussel MF, Sherr CJ. (2004). N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev 18:1862-1874.
18. Llanos S, Clark PA, Rowe J, Peters G. (2001). Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol 3:445-452.
19. Lohrum MA, Ashcroft M, Kubbutat MH, Vousden KH. (2000). Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization. Curr Biol 10:539-542.
20. Quelle DE, Cheng M, Ashmun RA, Sherr CJ. (1997). Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc Natl Acad Sci USA 94:669-673.
21. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. (1995). Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
22. Rizos H, Darmanian AP, Mann GJ, Kefford RF. (2000). Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization. Oncogene 19:2978-2985.
23. Rodway H, Llanos S, Rowe J, Peters G. (2004). Stability of nucleolar versus non-nucleolar forms of human p14(ARF). Oncogene 23: 6186-6192.
24. Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ. (1998). Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 17:554-564.
25. Sherr CJ. (2006). Divorcing ARF and p53:an unsettled case. Nat Rev Cancer 6:663-673.
26. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S et al. (1998). The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17:5001-5014.
27. Tao W, Levine AJ. (1999). P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc Natl Acad Sci USA 96: 6937-6941.
28. Weber JD, Kuo ML, Bothner B, DiGiammarino EL, Kriwacki RW, Roussel MF et al. (2000). Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol Cell Biol 20:2517-2528.
29. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. (1999). Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1: 20-26.
30. Zhang Y, Xiong Y. (1999). Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol Cell 3:579-591 .
31. Zhang Y, Xiong Y, Yarbrough WG. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-IN K4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725-734.